The Clinical Platform recruits and enrolls subjects into our specimen collection studies and first-in-human clinical trials. Specimens include blood, leukapheresis, mucosal swabs, urine, sputum and saliva samples, stool and other microbiome collections, and several tissue biopsy types. These samples provide Ragon investigators and collaborators with valuable information on how the body responds to infectious diseases. You can meet the team here.
The clinical platform supports a large number of projects in which samples have provided invaluable insight into some of the most pressing research questions. These include the discovery of the mechanisms by which elite controllers suppress HIV indefinitely, understanding how the vaginal microbiome can affect risk of contracting HIV, and COVID-19 patient samples from as early as March 2020, which were essential to a better understanding of COVID-19 and driving forward vaccine development.Read More
Clinical research provides valuable insight in the interactions of the immune system and various pathogens through the use of clinical samples such as blood draws and mucus swabs.READ MORE
The Ragon’s clinical research focuses on clinical studies in infectious diseases such as HIV and COVID-19.READ MORE